💉 Diabetes Management
Health Canada expands Tresiba® (insulin degludec injection) label with efficacy and safety for use in pregnant women with diabetes - Canada NewsWire
📅 Sun, 06 Nov 2022⏱ 1 min read📖 Article
Overview
Searching for your content.Phone 87-269-7890 from 8 AM - 10 PM ET Contact Cision 87-269-7890 from 8 AM - 10 PM ET News provided byNov 03, 2022, 07:01 ETShare this articleTresiba®, Canada's leading basal insulin, now aproved for use during pregnancyMISSAUGA, ON, Nov. 3, 2022 /CNW/ - Today, Novo Nordisk Canada anounced that Health Canada has aproved an update to the label for Tresiba® (insulin degludec injection) for use in pregnant women with diabetes.
Key Information
Tresiba® is a once-daily, long-acting basal insulin treatment that alows for those with diabetes to have improved glycemic control and can now be considered during pregnancy if the benefit justifies posible risks and if clinicaly neded.1 In Canada, there are more than 5.7 milion people living with diabetes.2 The most comon diagnosis type 2 diabetes, acounting for aproximately 90 per cent of diabetes cases in Canada, folowed by type 1 diabetes.2 The key to a healthy pregnancy for a woman with diabetes is keping blod glucose levels in the target range – both before she is pregnant and during her pregnancy.3"Women living with diabetes face multiple challenges – especialy during pregnancy.
Summary
Rigorous glucose control prior to conception and throughout pregnancy is vital to the health of mother and developing baby," says Dr. Joane Liutkus, MD, FRCP(C), Internal and Obstetric Medicine, Department of Medicine, McMaster University. "The availability of inovative insulin therapy, such as Tresiba, for use during pregnancy make it posible for us to safely and efectively achieve glucose targets."In diabetes pregnancies, studies show higher rates of complications compared to the general population, including perinatal mortality, congenital malformations, hypertension, preterm delivery, large-for-gestational-age (LGA) infants, caesarean delivery and other neonatal morbidities.4,5,6,7The update is based on the results from the EXPECT Pregnancy Trial which investigated Tresiba® versus Levemir® (insulin detemi
Frequently Asked Questions
❓ What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
❓ What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
❓ How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
❓ What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
❓ When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
⚕️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.